M0246 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency

Short descriptor: Bamlan and etesev infus home

⚠ Terminated HCPCS Level II 2026
Terminated Code
M0246 was terminated as of 2023-12-13 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open M0246 in the app →

Look up M0246 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

M0246 is the HCPCS Level II code for Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Vaccinations.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Vaccinations (indicator 54)
Type of Service
Pneumococcal/flu/hepatitis B vaccine
Effective Date
2023-12-14
Termination Date
2023-12-13
2026 Maintenance
No change this year

References

Cite This Page

Reference M0246 with the canonical source and edition:

M0246 — Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M0246

Canonical URL: https://icd10codingpro.com/hcpcs-codes/M0246

Related Codes in Section M

← M0245 Bamlan and etesev infusion M0247 → Sotrovimab infusion
M0241 Casiri and imdev repeat hm M0243 Casirivi and imdevi inj M0244 Casirivi and imdevi inj hm M0245 Bamlan and etesev infusion M0247 Sotrovimab infusion M0248 Sotrovimab inf, home admin M0249 Adm tocilizu covid-19 1st M0250 Adm tocilizu covid-19 2nd M0300 Iv chelationtherapy M0301 Fabric wrapping of aneurysm
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial